NeuroSpa TMS
NeuroSpa TMS is a Florida-based, private interventional psychiatry clinic network founded in 2018 that delivers FDA-approved Transcranial Magnetic Stimulation (TMS) therapy to patients with treatment-resistant depression, PTSD, and suicidality across 8+ clinic locations.
- Company typePrivate
- Founded2018
- HeadquartersTampa, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What NeuroSpa TMS does
NeuroSpa TMS is a private, Tampa-based interventional psychiatry clinic operator founded in 2018 that delivers pill-free, FDA-approved Transcranial Magnetic Stimulation (TMS) therapy to patients with treatment-resistant depression, PTSD, and suicidality. The company positions its clinics in a spa-like setting and concentrates exclusively on the interventional psychiatry use case, vertically segmented for patients who have not responded to conventional treatments. No proprietary technology stack beyond standard TMS devices is described in available sources, and pricing is not publicly disclosed.
The business model is service-based: revenue is generated per TMS procedure across a growing clinic footprint, with go-to-market executed through direct clinic operations and a network build-out strategy in Florida. Following a Dura Medical acquisition referenced in the dataset, the network has scaled to 8+ interventional psychiatry clinic locations in the state. A strategic partnership with Ampa Health, announced in November 2025, has introduced a first-in-Florida "one-day" depression treatment offering and integrates the clinic network with NRx Pharmaceuticals' pharmaceutical protocols through the broader HOPE Therapeutics ecosystem.
Strategically, NeuroSpa TMS sits within a depression treatment market projected to expand to $750M-$3.35B by 2034. Competitive positioning rests on clinical delivery, regional density in Florida, and bundled pharmaceutical-device protocols rather than software or AI-driven differentiation. Inputs on ownership, management team, financials, and formal corporate linkage to NRx/HOPE Therapeutics remain data gaps in the available sources.
NeuroSpa TMS firmographics
Firmographics- Name
- NeuroSpa TMS
- Website
- https://neurospatms.com
- Company type
- Private
- Founded year
- 2018
- Headcount range
- 11–50 employees
- Short description
- NeuroSpa TMS is a Florida-based, private interventional psychiatry clinic network founded in 2018 that delivers FDA-approved Transcranial Magnetic Stimulation (TMS) therapy to patients with treatment-resistant depression, PTSD, and suicidality across 8+ clinic locations.
- Ownership category
- akta.pro rank
NeuroSpa TMS industry classification
Industry- Product category
- Mental Health Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (62142)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
- akta.pro secondary industries
- Psychiatry & Medication Management Platforms (HLALAEAB), Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
Keywords
Where NeuroSpa TMS is headquartered
LocationHeadquarters
- HQ city
- Tampa
- HQ country
- United States
- HQ region
- North America
Markets served
NeuroSpa TMS business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
NeuroSpa TMS product offering
Product offeringCore offering
NeuroSpa TMS delivers Transcranial Magnetic Stimulation (TMS) therapy for patients with depression, PTSD, and suicidality in spa-like clinical settings. Treatment is FDA-approved, pill-free, and non-invasive, with the company operating 8 or more Florida locations. The company also offers a one-day depression treatment protocol through a partnership with Ampa Health and has expanded its footprint by acquiring Dura Medical.
Product overview
No product or service information available from the source data. The NeuroSpa TMS website (neurospatms.com) displayed only a loading/verification page without accessible content. The news sources reference TMS-related depression treatments in the broader healthcare industry but do not provide specific information about NeuroSpa TMS's own product portfolio, services, or offerings.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Expanding to 8+ interventional psychiatry clinic locations in Florida
Companies that use NeuroSpa TMS
Customer profileSegments1 record
Ideal customer profiles1 record
NeuroSpa TMS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NeuroSpa TMS partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ampa HealthcoreAmpa Health partnered with NRx Pharmaceuticals to launch the first-in-Florida 'One Day' depression treatment. This partnership leverages Ampa Health's healthcare delivery capabilities with NRx's pharmaceutical offerings to provide rapid depression treatment in Florida.
Scale indicators2 records
Recent moves4 records
Expansion highlights5 records
NeuroSpa TMS competitors and assessment
Company assessmentDirect peers
- TMS NeuroHealth Centers: Specialty TMS clinic group focused on treatment-resistant depression and related behavioral health conditions; directly comparable service line and patient population to NeuroSpa.
- Field Trip Health: Clinic network delivering interventional psychiatry (ketamine, TMS) for depression and PTSD; comparable interventional psychiatry clinic model.
- Success TMS: Multi-state TMS treatment provider for depression, anxiety, and PTSD; closely comparable specialty clinic model and patient demographic.
- MindPath Care Centers: Outpatient psychiatry group offering TMS alongside therapy and medication management; comparable multi-site interventional psychiatry model, though with broader service mix.
- Greenbrook TMS: Multi-site TMS clinic network treating depression and OCD; the most direct operating-model comparable to NeuroSpa's interventional psychiatry clinic footprint.
Broad incumbents
- Cerebral: Large behavioral health platform addressing depression and anxiety; competes for the same patient population but primarily via telehealth and medication management.
- Talkiatry: Tech-enabled outpatient psychiatry group (and acquirer of Greenbrook TMS); competes for the same patient population, albeit with a primarily telehealth-first delivery model.
Emerging players
- Bespoke Treatment: Interventional psychiatry practice offering TMS, ketamine, and SPRAVATO; overlaps with NeuroSpa on interventional modalities for treatment-resistant depression.
Regional players
- Pasadena Recovery Center: Regional behavioral health provider offering psychiatric services including TMS-adjacent modalities; comparable patient base but different geographic market.
Others
- NRx Pharmaceuticals: Partner/strategic counterparty of NeuroSpa-affiliated clinics via Ampa Health; relevant as a pharmaceutical partner for the 'One Day' depression protocol rather than a direct competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
NeuroSpa TMS financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroSpa TMS leadership team
Management profileNumber of profiles
NeuroSpa TMS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroSpa TMS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroSpa TMS
What does NeuroSpa TMS do?
NeuroSpa TMS delivers Transcranial Magnetic Stimulation (TMS) therapy for patients with depression, PTSD, and suicidality in spa-like clinical settings. Treatment is FDA-approved, pill-free, and non-invasive, with the company operating 8 or more Florida locations. The company also offers a one-day depression treatment protocol through a partnership with Ampa Health and has expanded its footprint by acquiring Dura Medical.
Is NeuroSpa TMS a public or private company?
NeuroSpa TMS is a private company. It is classified as unknown.
When was NeuroSpa TMS founded?
NeuroSpa TMS was founded in 2018. It employs 11 to 50 people.
Where is NeuroSpa TMS based?
NeuroSpa TMS is headquartered in Tampa, United States, in the North America region.
Who are NeuroSpa TMS's main competitors?
Direct peers on record are TMS NeuroHealth Centers, Field Trip Health, Success TMS, MindPath Care Centers and Greenbrook TMS. Broad incumbents are Cerebral and Talkiatry. Bespoke Treatment is listed as an emerging player. Pasadena Recovery Center is listed as a regional player. NRx Pharmaceuticals is listed as an others.
Does NeuroSpa TMS have an API?
No public API is recorded for NeuroSpa TMS.
What industry is NeuroSpa TMS in?
NeuroSpa TMS's product category is Mental Health Services. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621112 and its SIC code is 8011.